Quick Answer
Upstream Bio, Inc. reported Total Revenue of $2.85 million for the year ending 2025.
- Upstream Bio, Inc. showed an increase of +20.4% in Total Revenue from 2024 to 2025.
- This data is from Upstream Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: $621.0 thousand | Q1 2024: $640.0 thousand | Q2 2024: $510.0 thousand | Q3 2024: $607.0 thousand | Q1 2025: $566.0 thousand | Q2 2025: $937.0 thousand | Q3 2025: $683.0 thousand.
- Over the full 3 years of available data (2023 to 2025), Upstream Bio, Inc.'s Total Revenue has grown by 19.9%.
- Historical annual values: Fiscal year 2025: $2.85 million | Fiscal year 2024: $2.37 million | Fiscal year 2023: $2.38 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: